$14.47
0.090.63%
In chiusura: -
$14.39
-0.08-0.55%
After hour: 6:31 PM EDT
Adaptive Biotechnologies segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Adaptive Biotechnologies utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ADPT | Adaptive Biotechnologies | -$0.22 | -$0.18 | — | — | $46.44M | $59.12M | — | — | 11/06/2025 | |
ADPT | Adaptive Biotechnologies | -$0.31 | -$0.24 | -$0.17 | 29.17% | $43.19M | $49.52M | $58.88M | 18.90% | 08/05/2025 | |
ADPT | Adaptive Biotechnologies | -$0.33 | -$0.31 | -$0.20 | 35.48% | $41.87M | $42.13M | $52.40M | 24.38% | 05/01/2025 | |
ADPT | Adaptive Biotechnologies | -$0.30 | -$0.24 | -$0.23 | 4.17% | $45.78M | $46.05M | $47.46M | 3.06% | 02/11/2025 | |
ADPT | Adaptive Biotechnologies | -$0.35 | -$0.29 | -$0.22 | 24.14% | $37.92M | $40.21M | $46.44M | 15.48% | 11/07/2024 | |
ADPT | Adaptive Biotechnologies | -$0.33 | -$0.33 | -$0.31 | 6.06% | $48.93M | $38.66M | $43.19M | 11.72% | 08/01/2024 | |
ADPT | Adaptive Biotechnologies | -$0.40 | -$0.34 | -$0.33 | 2.94% | $37.65M | $38.78M | $41.87M | 7.98% | 05/07/2024 | |
ADPT | Adaptive Biotechnologies | -$0.28 | -$0.30 | -$0.30 | 0.00% | $55.20M | $48.46M | $45.78M | -5.52% | 02/14/2024 | |
ADPT | Adaptive Biotechnologies | -$0.32 | -$0.34 | -$0.35 | -2.94% | $47.83M | $42.96M | $37.92M | -11.73% | 11/09/2023 | |
ADPT | Adaptive Biotechnologies | -$0.37 | -$0.33 | -$0.33 | 0.00% | $43.66M | $45.48M | $48.93M | 7.58% | 08/02/2023 | |
ADPT | Adaptive Biotechnologies | -$0.44 | -$0.38 | -$0.40 | -5.26% | $38.62M | $36.81M | $37.65M | 2.27% | 05/03/2023 | |
ADPT | Adaptive Biotechnologies | -$0.43 | -$0.35 | -$0.28 | 20.00% | $37.93M | $55.27M | $55.20M | -0.13% | 02/14/2023 | |
ADPT | Adaptive Biotechnologies | -$0.40 | -$0.37 | -$0.32 | 13.51% | $39.47M | $48.67M | $47.83M | -1.73% | 11/03/2022 | |
ADPT | Adaptive Biotechnologies | -$0.35 | -$0.43 | -$0.37 | 13.95% | $38.51M | $42.16M | $43.66M | 3.56% | 08/03/2022 | |
ADPT | Adaptive Biotechnologies | -$0.29 | -$0.45 | -$0.44 | 2.22% | $38.44M | $37.71M | $38.62M | 2.41% | 05/04/2022 | |
ADPT | Adaptive Biotechnologies | -$0.33 | -$0.45 | -$0.43 | 4.44% | $30.18M | $36.37M | $37.93M | 4.29% | 02/15/2022 | |
ADPT | Adaptive Biotechnologies | -$0.27 | -$0.42 | -$0.40 | 4.76% | $26.30M | $36.64M | $39.47M | 7.72% | 11/03/2021 | |
ADPT | Adaptive Biotechnologies | -$0.26 | -$0.42 | -$0.35 | 16.67% | $20.99M | $31.26M | $38.51M | 23.18% | 08/04/2021 | |
ADPT | Adaptive Biotechnologies | -$0.25 | -$0.41 | -$0.29 | 29.27% | $20.91M | $27.75M | $38.44M | 38.53% | 05/05/2021 | |
ADPT | Adaptive Biotechnologies | -$0.17 | -$0.29 | -$0.33 | -13.79% | $24.21M | $26.90M | $30.18M | 12.21% | 02/24/2021 | |
ADPT | Adaptive Biotechnologies | -$0.11 | -$0.28 | -$0.27 | 3.57% | $26.06M | $23.58M | $26.30M | 11.53% | 11/10/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-05 | $-0.17 | $-0.24 | 29.2 % |
Q1 | 2025-05-01 | $-0.20 | $-0.31 | 35.5 % |
Q4 | 2025-02-11 | $-0.23 | $-0.24 | 4.17 % |
Q3 | 2024-11-07 | $-0.22 | $-0.29 | 24.1 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-05 | $58.88M | $49.52M | 18.9 % |
Q1 | 2025-05-01 | $52.40M | $42.13M | 24.4 % |
Q4 | 2025-02-11 | $47.46M | $46.05M | 3.06 % |
Q3 | 2024-11-07 | $46.44M | $40.21M | 15.5 % |
Si prevede che Adaptive Biotechnologies (ADPT) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 5, 2025 per il Q2.
L'EPS effettivo era $-0.17, che superato la stima di $-0.24.
Le entrate effettive sono state $58.9M, che superato la stima di $49.5M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.